Dietary quercetin is recovered in rat plasma as conjugated derivatives of isorhamnetin and quercetin

被引:98
作者
Manach, C
Texier, O
Regerat, F
Agullo, G
Demigne, C
Remesy, C
机构
[1] INRA,MALAD METAB LAB,F-63122 ST GENES CHAMPANE,FRANCE
[2] FAC PHARM CLERMONT FERRAND,LAB PHARMACOGNOSIE & BIOTECHNOL,F-63001 CLERMONT FERRAN,FRANCE
关键词
quercetin; rat; metabolism; isorhamnetin; albumin; ESTROGEN-BINDING-SITES; CARCINOGENICITY TEST; CANCER CELLS; FLAVONOIDS; GROWTH; RUTIN; INHIBITION; GENISTEIN;
D O I
10.1016/S0955-2863(96)00058-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quercetin is present in noticeable amount in human diet and this polyphenolic molecule is supposed to exert beneficial effects on human health. However, its intestinal absorption and its metabolic fate in the organism have not received much attention. In the present study, rats were fed a control or a 0.25% quercetin diet, and the plasma, urine, and bile metabolites of the dietary quercetin were analyzed by HPLC. Conjugated derivatives of quercetin and isorhamnetin, a 3'-O-methylated form of quercetin, were identified in the plasma from the rats fed quercetin. After deconjugation, the concentration of aglycones in the plasma reached 120 +/- 16 mu mol/L, with an isorhamnetin/quercetin ratio of about 5. In bile and in urine, where the 4-oxo-flavonoid concentration were 378 +/- 42 and 128 +/- 19 mu mol/L respectively, conjugated derivatives of quercetin and isorhamnetin, but also of tamarixetin, a 4'-O-methylated form of quercetin were recovered. In plasma, the 4-oxo-flavonoid metabolites are bound to albumin, which induces a bathochromic effect. The bathochromic and chromogenic responses depend on the presence of the unsaturated C2-C3 bound of the C-ring and on the presence of hydroxyl groups on the B-ring. Studies on 4-oxo-flavonoid bioavailability could allow a better understanding of the nutritional effects of various type of plant products.
引用
收藏
页码:375 / 380
页数:6
相关论文
共 38 条
[21]   URINARY PRODUCTS FROM QUERCETIN IN NEOMYCIN-TREATED RATS [J].
NAKAGAWA, Y ;
SHETLAR, MR ;
WENDER, SH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1965, 97 (02) :233-&
[22]  
PAMUKCU AM, 1980, CANCER RES, V40, P3468
[23]   GENISTEIN AND BIOCHANIN-A INHIBIT THE GROWTH OF HUMAN PROSTATE-CANCER CELLS BUT NOT EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE AUTOPHOSPHORYLATION [J].
PETERSON, G ;
BARNES, S .
PROSTATE, 1993, 22 (04) :335-345
[24]   GROWTH INHIBITORY EFFECTS OF BIOFLAVONOIDS AND RELATED-COMPOUNDS ON HUMAN LEUKEMIC CEM-C1 AND CEM-C7 CELLS [J].
POST, JFM ;
VARMA, RS .
CANCER LETTERS, 1992, 67 (2-3) :207-213
[25]  
Saito D, 1980, Teratog Carcinog Mutagen, V1, P213
[26]   QUERCETIN INHIBITS THE GROWTH OF A MULTIDRUG-RESISTANT ESTROGEN-RECEPTOR-NEGATIVE MCF-7 HUMAN BREAST-CANCER CELL-LINE EXPRESSING TYPE-II ESTROGEN-BINDING SITES [J].
SCAMBIA, G ;
RANELLETTI, FO ;
PANICI, PB ;
PIANTELLI, M ;
BONANNO, G ;
DEVINCENZO, R ;
FERRANDINA, G ;
PIERELLI, L ;
CAPELLI, A ;
MANCUSO, S .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (04) :255-258
[27]   INHIBITORY EFFECT OF QUERCETIN ON OVCA-433 CELLS AND PRESENCE OF TYPE-II ESTROGEN BINDING-SITES IN PRIMARY OVARIAN-TUMORS AND CULTURED-CELLS [J].
SCAMBIA, G ;
RANELLETTI, FO ;
PANICI, PB ;
PIANTELLI, M ;
BONANNO, G ;
DEVINCENZO, R ;
FERRANDINA, G ;
RUMI, C ;
LAROCCA, LM ;
MANCUSO, S .
BRITISH JOURNAL OF CANCER, 1990, 62 (06) :942-946
[28]   SULFATION OF THE FLAVONOIDS QUERCETIN AND CATECHIN BY RAT-LIVER [J].
SHALI, NA ;
CURTIS, CG ;
POWELL, GM ;
ROY, AB .
XENOBIOTICA, 1991, 21 (07) :881-893
[29]  
SHIMAMURA H, 1993, BIOL PHARM BULL, V16, P899
[30]   QUERCETIN IN OUR DIET - FROM POTENT MUTAGEN TO PROBABLE ANTICARCINOGEN [J].
STAVRIC, B .
CLINICAL BIOCHEMISTRY, 1994, 27 (04) :245-248